By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Integrated DNA Technologies today announced a co-marketing agreement for qPCR products.

The agreement covers Agilent's Mx3005P qPCR system and Brilliant qPCR reagents and IDT's PrimeTime qPCR assays.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.